Highlights and Quick Summary
- Interest Expense (Operating) for the quarter ending February 28, 2022 was $70.9 Thousand (a 9.29% increase compared to previous quarter)
- Year-over-year quarterly Interest Expense (Operating) decreased by -80.33%
- Annual Interest Expense (Operating) for 2021 was $2.35 Million (a -48.78% decrease from previous year)
- Annual Interest Expense (Operating) for 2020 was $4.59 Million (a -36.91% decrease from previous year)
- Annual Interest Expense (Operating) for 2019 was $7.27 Million (a -6.38% decrease from previous year)
- Twelve month Interest Expense (Operating) ending February 28, 2022 was $604 Thousand (a -48.29% decrease compared to previous quarter)
- Twelve month trailing Interest Expense (Operating) decreased by -79.5% year-over-year
Trailing Interest Expense (Operating) for the last four month:
| 28 Feb '22 | 30 Nov '21 | 31 Aug '21 | 31 May '21 |
|---|---|---|---|
| $604 Thousand | $1.17 Million | $2.32 Million | $2.95 Million |
Visit stockrow.com/OGI
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Interest Expense (Operating) of Organigram Holdings Inc.
Most recent Interest Expense (Operating)of OGI including historical data for past 10 years.Interactive Chart of Interest Expense (Operating) of Organigram Holdings Inc.
Organigram Holdings Inc. Interest Expense (Operating) for the past 10 Years (both Annual and Quarterly)
(All values are in $ million)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2022 | $0.07 | – | – | – | – |
| 2021 | $0.06 | $0.11 | $0.36 | $0.63 | $2.35 |
| 2020 | $1.22 | $0.73 | $1.62 | $1.46 | $4.59 |
| 2019 | – | – | – | – | $7.27 |
| 2018 | – | – | – | – | $7.76 |
| 2017 | – | – | – | – | $0.21 |
| 2016 | – | – | – | – | $0.33 |
Business Profile of Organigram Holdings Inc.
Sector: Healthcare
Industry: Drug Manufacturers Specialty & Generic